drugset / Trial / NCT01687309

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender

NCT01687309

Phase 1 Completed 19 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and repeat doses of 800 mg GSK2586184 in healthy subjects.

Timeline

Start
2012-04-30
Primary completion
2012-07-31
Completion
2012-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator SOLCITINIB Small molecule 800 mg